Torrent Pharmaceuticals reports 13.29 percent decline in net profit at Rs 163 crore for Q1
The company had posted a net profit of Rs 188 crore during the same period of the previous fiscal.
Revenue of the company, however, increased by 37 percent during the April-June period of the current fiscal at Rs 1,872 crore as compared with Rs 1,362 crore during the same period of last year, Torrent Pharma said in a regulatory filing.
Amortisation impact of acquiring the branded business of Unichem Laboratories in December 2017 and lower foreign exchange gains impacted the company's profit during the first quarter, it added.
Shares of Torrent Pharma today ended 0.14 percent down at Rs 1,522.70 apiece on the BSE.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)